Vaxart, Inc. VXRT
0.40 USD -0.01 (-1.84%)
Nov 3, 2026, 3:59 PM EST
0.3851 Day range 0.41
0.31 52-week range 0.84
- YTD
- +14.29%
- 1 year
- +21.21%
Analyst view
Price target (mean) 4.83 +1108.3% upside
Now 0.40
- Target (low)
- 2.50
- Target (mean)
- 4.83
- Target (high)
- 8.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.11 | -0.11 – -0.11 | -0.12 | +8.3% | 15.68M | +383.3% | 3 |
| Next quarter | -0.12 | -0.16 – -0.09 | -0.14 | +14.3% | 8.32M | +281.7% | 3 |
| Current year | -0.40 | -0.40 – -0.40 | -0.57 | +29.8% | 34.28M | +364.6% | 2 |
| Next year | -0.41 | -0.54 – -0.27 | -0.40 | -2.5% | 29.50M | -13.9% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 15, 2024 | Oppenheimer | Initiated | — | Outperform |
| Jan 31, 2024 | B. Riley Securities | Upgrade | Neutral | Buy |
| Sep 7, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 7, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Dec 19, 2022 | B. Riley Securities | Maintained | — | Neutral |
| Sep 2, 2022 | Cantor Fitzgerald | Maintained | — | Overweight |
| May 19, 2022 | B. Riley Securities | Maintained | — | Neutral |
| Nov 2, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 30, 2021 | B. Riley Securities | Downgrade | Buy | Neutral |
| Jun 24, 2021 | Jefferies | Initiated | — | Buy |
| Jun 11, 2021 | Piper Sandler | Initiated | — | Overweight |
| Aug 12, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jul 13, 2020 | B. Riley Securities | Initiated | — | Buy |
| Apr 30, 2020 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jun 27, 2019 | HC Wainwright & Co. | Initiated | — | Buy |